Skip to content
← Full study record

NCT01182350 · MORE INFO

Limitations, agreements, and source contact

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) · Source last updated 2019-09-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study was terminated early having met the pre-specified stopping rule which required 3 or more cohorts with at least 10 patients each or 2 cohorts with at least 15 patients each in the first 50 patients with informative biopsies.
point Of Contact
email
KarenD_Wright@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617.632.6740
title
Karen Wright
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study was terminated early having met the pre-specified stopping rule which required 3 or more cohorts with at least 10 patients each or 2 cohorts with at least 15 patients each in the first 50 patients with informative biopsies.
point Of Contact
email
KarenD_Wright@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617.632.6740
title
Karen Wright

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice